Boehringer Ingelheim India picks Gagandeep Singh as its new MD & Head of Human Pharma
INDIA – Global drug firm Boehringer Ingelheim has hired Gagandeep Singh Bedi as the company’s new Managing Director and Head of Human Pharma for the Indian region following the exit of Vani Manja.
Gagandeep Singh will take up his new role as MD & Head of Human Pharma of Boehringer Ingelheim India on 10th July 2023 after the transition period is complete.
According to the company’s statement, Gagandeep has also been selected to join the Board of Directors of Boehringer Ingelheim India.
He is a seasoned pharmaceutical sales professional with close to two decades of leadership experience in the healthcare industry.
Commenting on the elevation, Gagandeep Singh said: “I am excited to take on the leadership role at Boehringer Ingelheim India and work alongside an exceptionally talented team.”
The industry veteran has a deep understanding of patient expectations and practical expertise in pharmaceutical sales functions across large firms in the sector.
Prior to his appointment, Gagandeep served at AstraZeneca, a global, science-led biopharmaceutical business, since February 2006.
He progressed through multiple executive positions at AstraZeneca including serving as Managing Director for India and Africa Cluster Head.
Gagandeep also previously served as the Chief Financial Officer of Fortis Healthcare; an Indian multinational chain of private hospitals headquartered in India.
Unsurprisingly, he has an excellent track record of leading corporate strategy at multinational pharmaceutical companies in India and several emerging market economies.
The new Boehringer Ingelheim India MD has in-depth organizational knowledge to drive business growth in the country as India’s pharmaceutical sector keeps changing and evolving.
“Changing patients’ lives starts with a commitment to identifying health challenges of the future and enabling access to medicines. I look forward to driving value through innovation as we address the healthcare needs of the Indian population,” underscored Gagandeep.
He is well suited to drive the company’s growth and profitability in India as well as provide patients with innovative medicines and sustainable care.
Welcoming Gagandeep into the leadership team, Mohammed Tawil, Regional MD and Head of Human Pharma for India, Middle East, Turkey, and Africa at Boehringer Ingelheim, said: “Gagandeep’s passion for fostering a customer-focused culture and his experience across complex health ecosystems will be invaluable to the organization.”
This leadership change comes as the company strives to achieve its strategic goals and strengthen its sustainability commitment to India.
He is expected to help address specific patient needs and healthcare challenges as the nation faces a significantly growing burden of non-communicable diseases, particularly affecting India’s young population.
Gagandeep will take over the MD & Head of Human Pharma role from Vani Manja, who relocated to the United Kingdom in February 2023.
The former executive Vani Manja left the role to serve as the new Country Managing Director and Head of Human Pharma of Boehringer Ingelheim for the UK & Ireland region.
In her new stint, Vani is working closely with key stakeholders across the healthcare ecosystem in the company’s collective quest to improve health for humans and animals in the UK and Ireland.
Commenting on the leadership changes, Mohammed Tawil said: “I would like to thank Sandip Agarwal for his leadership during the transition where he ensured sustained growth and business continuity.”
Sandip Agrawal, Director of Finance and Administration at Boehringer Ingelheim India, took over the added responsibility of Interim Managing Director following the departure of Vani earlier this year.
Gagandeep Singh will be taking the reins from Sandip Agrawal who took up an interim role as Boehringer Ingelheim India MD in February 2023.
Consequently, Gagandeep will assume responsibility for the company’s pharma business vertical for the Indian market on 10th July 2023, filling the position vacated by Vani Manja.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
Be the first to leave a comment